These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3551995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A, McCans J, Willan AR, Ford PM.
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [Abstract] [Full Text] [Related]

  • 3. Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon.
    Nahir AM, Schapira D, Scharf Y.
    Isr J Med Sci; 1986 Feb; 22(2):139-42. PubMed ID: 3081460
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J, Kraus A, González-Amaro R, Alarcón-Segovia D.
    J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
    [Abstract] [Full Text] [Related]

  • 6. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J, Wouda AA, Kallenberg CG, Wesseling H.
    Vasa Suppl; 1987 Jun; 18():71-5. PubMed ID: 3299819
    [No Abstract] [Full Text] [Related]

  • 7. Thymoxamine for Raynaud's disease and chilblains.
    Jaffe GV, Grimshaw JJ.
    Br J Clin Pract; 1980 Jun; 34(11-12):343-6. PubMed ID: 6450602
    [No Abstract] [Full Text] [Related]

  • 8. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O, Schmidt JF, Ironmann L.
    Ugeskr Laeger; 1983 Dec 05; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Local treatment with isosorbide dinitrate ointment in Raynaud's phenomenon].
    Diehm C, Müller-Bühl U, Mechterscheimer U, Mörl H.
    Vasa; 1984 Dec 05; 13(1):72-4. PubMed ID: 6367258
    [No Abstract] [Full Text] [Related]

  • 11. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C, Tonelli V, Bonifacio M, Mari A, Assogna G.
    Boll Chim Farm; 1985 Oct 05; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M, Polaszewska-Muszyńska M, Ukleja-Adamowicz M, Rewakowicz M, Guzowska M, Marunowska A, Jundziłł W, Wodyńska T, Ruchalski M, Strzelecki A.
    Kardiol Pol; 1987 Oct 05; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract] [Full Text] [Related]

  • 14. Isosorbide dinitrate ointment in Raynaud's disease.
    Diehm C, Müller-Bühl U, Mörl H.
    Z Kardiol; 1983 Oct 05; 72 Suppl 3():185-7. PubMed ID: 6364591
    [Abstract] [Full Text] [Related]

  • 15. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
    Holti G.
    Practitioner; 1982 Apr 05; 226(1366):781-3. PubMed ID: 7045853
    [No Abstract] [Full Text] [Related]

  • 16. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Apr 05; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 17. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS, Gilgor RS, Allen LM, Duvic M.
    Arch Dermatol; 1984 Mar 05; 120(3):329-31. PubMed ID: 6367665
    [Abstract] [Full Text] [Related]

  • 18. Topical nitroglycerin ointment in Raynaud's phenomenon.
    Fischer M, Reinhold B, Falck H, Török M, Alexander K.
    Z Kardiol; 1985 May 05; 74(5):298-302. PubMed ID: 3925656
    [Abstract] [Full Text] [Related]

  • 19. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
    Rustin MH, Grimes SM, Kovacs IB, Cooke ED, Bowcock SA, Sowemimo-Coker SO, Turner P, Kirby JD.
    Eur J Clin Pharmacol; 1984 May 05; 27(1):61-5. PubMed ID: 6386490
    [Abstract] [Full Text] [Related]

  • 20. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
    Dumoulin J.
    Electrodiagn Ther; 1981 May 05; 18(4):168-74. PubMed ID: 6279383
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.